Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study

Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study

Metastasis development represents an important threat for melanoma patients, even when diagnosed at early stages and upon removal of the primary tumor. In this scenario, determination of prognostic biomarkers would be of great interest. Serum contains information about the general status of the orga...

Full description

Bibliographic Details
Main Authors: Filippo Mancuso, Sergio Lage, Javier Rasero, José Luis Díaz‐Ramón, Aintzane Apraiz, Gorka Pérez‐Yarza, Pilar Ariadna Ezkurra, Cristina Penas, Ana Sánchez‐Diez, María Dolores García‐Vazquez, Jesús Gardeazabal, Rosa Izu, Karmele Mujika, Jesús Cortés, Aintzane Asumendi, María Dolores Boyano
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Molecular Oncology
Subjects:
dermcidin
interleukins
melanoma
prognosis
serum biomarkers
Online Access:https://doi.org/10.1002/1878-0261.12732

Similar Items

Similar Items